Vapotherm, Inc. (VAPO)

Market Cap	13.59M
Revenue (ttm)	70.92M
Net Income (ttm)	-54.42M
Shares Out	6.26M
EPS (ttm)	-8.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,038
Open	2.170
Previous Close	2.180
Day's Range	2.170 - 2.170
52-Week Range	2.100 - 2.180
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Vapotherm

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companio...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 182
• Stock Exchange: OTCMKTS
• Ticker Symbol: VAPO

Financial Performance

In 2023, Vapotherm's revenue was $68.67 million, an increase of 2.80% compared to the previous year's $66.80 million. Losses were -$58.19 million, -48.62% less than in 2022.